Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Farzad Mortazavi
Based on 4 articles published since 2009
(Why 4 articles?)
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 4 published articles on Parkinson Disease from 2009 through 2019, it is not possible for Expertscape to reliably rate Farzad Mortazavi's expertise on this topic.

Work Locations
Details
Most likely:    UCLA   Contact    
2017
  • Department of Neurology, UCLA, Los Angeles, CA, USA. Electronic address: · Department of Neurology, UCLA, Los Angeles, CA, USA. · Hatos Center, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA. · Pubmed 28038352
2014
  • The David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095-1769, USA. · Pubmed 25037721
2011
  • Departments of Neurology and Neurobiology, The David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA 90095-1769, USA. · Pubmed 21193046
2009
  • Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90095, USA. · Pubmed 19228951
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Farzad Mortazavi in 2009-2019 about Parkinson Disease:

  • Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice. 2017
  • A GCase chaperone improves motor function in a mouse model of synucleinopathy. 2014
  • A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions. 2011
  • Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. 2009
Show List of Full Article Records
Google Searches

Learn more about Farzad Mortazavi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
UCLA
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
UCLA
2017
  • Department of Neurology, UCLA, Los Angeles, CA, USA. Electronic address: · Department of Neurology, UCLA, Los Angeles, CA, USA. · Hatos Center, Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA. · Pubmed 28038352
2014
  • The David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA, 90095-1769, USA. · Pubmed 25037721
2011
  • Departments of Neurology and Neurobiology, The David Geffen School of Medicine at UCLA, 710 Westwood Plaza, Los Angeles, CA 90095-1769, USA. · Pubmed 21193046
2009
  • Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90095, USA. · Pubmed 19228951
Yearly article counts 00100100101
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.